Joel Embiid returned to the Philadelphia 76ers lineup on April 28, 2026, leading the team to a Game 5 victory over the Boston Celtics [1, 2].
The win is critical for Philadelphia as it keeps the team alive in the Eastern Conference semifinals and provides a path to force a Game 7 [1, 3].
Embiid delivered a dominant performance at TD Garden in Boston, scoring 28 points and recording 12 rebounds [1]. A Yahoo Sports analyst said Embiid came back and put on a clinic in the win [1]. The performance followed a period of recovery from a prior injury [1, 3].
Philadelphia secured the win through a decisive fourth-quarter surge. The 76ers outscored Boston 28-11 in the final period [2]. This stretch included a 12-0 run that shifted a one-possession game into a double-digit lead [2]. A reporter for The Philadelphia Inquirer said the run highlighted the team's ability to close the game [2].
The return of Embiid has produced mixed results for the 76ers throughout the series. In Game 4, the team suffered a 128-96 loss to the Celtics [4]. Dave DeGeorge of The Morning Call said Embiid’s return in Game 4 was a Faustian bargain, and the result showed the risk of relying on a player with lingering health concerns [4].
Despite the previous setback, the Game 5 victory shifts the momentum back toward Philadelphia. The 76ers now look to leverage Embiid's presence in the paint to neutralize Boston's defense as the series continues [1, 2].
“Embiid came back and put on a clinic, scoring 28 points and pulling down 12 rebounds in the win.”
The 76ers' ability to advance depends on Embiid's health and consistency. While his Game 5 performance proves he can dominate the Celtics' interior defense, the heavy loss in Game 4 suggests a volatile risk-reward profile. Philadelphia must balance his minutes to avoid reinjury while maintaining the offensive output necessary to overcome Boston's home-court advantage.
